Emerging Medical Technology Symposium

a Special Event @ InnoTech

11:30am – 6:30pm
Tuesday, April 16, 2013
Room: 101/102

REGISTRATION INFORMATION:
Registration for the 5th Annual Emerging Medical Technology Symposium is $54.00 and includes lunch, EMT presentations, evening reception, and access to InnoTech (on April 17, 2013).

Sponsored by:

Emerging Medical Technology Symposium Agenda

11:00am – 11:30am
Registration

11:30am – 1:00pm
Luncheon and Keynote Presentation

Wm. Cameron Powell MD President, Chief Medical Officer and Co-Founder AirStrip Technologies

-Hear how the idea of remote patient monitoring evolved from an initial idea to being one of the first mobile device platforms
-Learn about Airstrip’s greatest challenges for securing funding and learn at what stages they raised money
-Gain insights to their strategies for regulatory approval while being HIPPA compliant
-Discover how Airstrip set-up their distribution channels to catapult their business growth
-Find out what worked and what didn’t work (lessons learned)

1:15pm – 2:15pm
Session One – Critical Legal Changes:  IP, Taxation & Regulatory

	Cassia Ysaguirre, Associate, Strasburger Price, San Antonio, TX (Moderator)
	Michael Stimson, Senior Patent Counsel, Fulbright & Jaworski, San Antonio, TX
	Jessica Gonzalez, Senior Manager, Business Tax Services, Ernst & Young, LLP, San Antonio, TX
	Michael Shearn, Compliance and Regulatory Counsel, HealthCare & Life Sciences

The legal environment is constantly changing and compliance to new laws are critical for your business.  Hear our expert speakers discuss provisions of the new patent law (effective March 16, 2013) and its practical implications for the medical technology industry. Learn about key tax law changes resulting in the new medical device tax.  Most importantly, in order to sell your medical product, regulatory clearance is needed.  This panel will cover:

-Introduction to the America’s Invents Act (AIA) and the new publication practices
-Strategies for building patent portfolios and for thwarting competitor patent claims
-Understanding of the tax law changes and its implication for your bottom line
-Key strategies for US and worldwide regulatory approvals –is one faster than the other?
-Overview of new guidances and requirements to be aware of

2:30pm – 3:30pm
Session Two - Show me the Money! Fundraising Tips and Strategies

	Mark Jennings, CEO, Allermune Biomedical, LLC  (Moderator)
	George Karutz, Managing Director, Pasadera Capital
	Evan Melrose, MD, MBA, Managing Director, SpindleTop Capital
	Paul Castella, PhD, MBA, Co-founder and Director of Incyte Ventures

Funding can come from a variety of sources, including state grants, angel investors, venture capital groups or public stock offering.  Hear from experts on how to be most successful with getting your funding.

-Learn about the advantages/disadvantages of different “money”
-Understand the ideal way to approach raising money and the progression from seed to angel and when to go to the next level
-Find out what role your business plan plays in this fundraising process
-Know how much ownership investors would like to have in a company and why?

3:30pm – 4:00pm
Afternoon Refreshment Break – Exhibitor Showcase

-Service Providers
-Networking Fair
-Exhibitor Tables/Information:

4:00pm – 4:45pm
Session Three - Company Spotlights

York Duncan, President, Texas Research & Technology Foundation(moderator)

Invited medical start-up companies will have 5 minutes to make their pitch.  Pitches will be rated by three judges and best pitch will be awarded $1000, thanks to the generous support of T3DC.

 Judges include:
Randy Goldsmith
Becky Cap
Jim Poage

4:45pm – 5:00pm 

Wrap-Up and Closing Remarks

5:00pm – 6:30pm
Reception / Networking / Happy Hour
Announcement of Pitch Winner

Thank you to our 2013 Exhibitors:

Thank you to the Emerging Medical Technology Advisory Board

for lending their time & expertise to the event:

COMMITTEE CHAIR: Gabriele G. Niederauer, PhD, Senior VP, Technology & Development, ENTrigue Surgical, Inc.
Cassia M. Ysaguirre Associate Strasburger Price Oppenheimer Blend	Mark Horsey CFO Rapamyacin Holdings, Inc
Gary Litwin Operations Manager ENTrigue Surgical, Inc.	Matt Scherer Owner SCHERER COMMUNICATIONS
Corey Levenson, PhD Chief Scientific Officer ViroXis Corporation